Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation

Clinical Science

Volumn 124, Issue 8, 2013, Pages 491-507

  Bijland, Silvia ^a   Mancini, Sarah J ^a   Salt, Ian P ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adipose; Amp activated protein kinase (AMPK); Diabetes; Inflammation; Obesity

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; 6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ACETYL COENZYME A CARBOXYLASE; ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADIPOCYTOKINE; ADIPONECTIN; BERBERINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CALMODULIN; CHOLESTEROL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYSTATHIONINE BETA SYNTHASE; GHRELIN; GLUCOSE; GLUCOSE TRANSPORTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; ISOPRENOID; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; OLIGOSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; RESVERATROL; ROSIGLITAZONE; UNINDEXED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CARBOHYDRATE METABOLISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME STRUCTURE; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GLUCONEOGENESIS; GLUCOSE TRANSPORT; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TANDEM REPEAT; TISSUE METABOLISM;

ADIPOSE TISSUE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; OBESITY;

EID: 84872401752     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120536     Document Type: Article

References (180)

1. Carling, D., Thornton, C., Woods, A. and Sanders, M. J. (2012) AMP-activated protein kinase: new regulation, new roles? Biochem. J. 445, 11-27
2. Hardie, D. G., Ross, F. A. and Hawley, S. A. (2012) AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251-262
3. Viollet, B. and Andreelli, F. (2011) AMP-activated protein kinase and metabolic control. Handb. Exp. Pharmacol. 203, 303-330
4. Salt, I. P. and Palmer, T. M. (2012) Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation. Expert Opin. Investig. Drugs 21, 1155-1167
5. Glass, C. K. and Olefsky, J. M. (2012) Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 15, 635-645
6. Marzolla, V., Armani, A., Zennaro, M. C., Cinti, F., Mammi, C., Fabbri, A., Rosano, G. M. and Caprio, M. (2012) The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism. Mol. Cell. Endocrinol. 350, 281-288
7. Tam, C. S., Lecoultre, V. and Ravussin, E. (2012) Brown adipose tissue: mechanisms and potential therapeutic targets. Circulation 125, 2782-2791
8. Daval, M., Foufelle, F. and Ferre, P. (2006) Functions of AMP-activated protein kinase in adipose tissue. J. Physiol. 574, 55-62
9. Berggreen, C., Gormand, A., Omar, B., Degerman, E. and Göransson, O. (2009) Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am. J. Physiol. Endocrinol. Metab. 296, E635-E646
10. Fox, C. S., Massaro, J. M., Hoffmann, U., Pou, K. M., Maurovich-Horvat, P., Liu, C. Y., Vasan, R. S., Murabito, J. M., Meigs, J. B., Cupples, L. A. et al. (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116, 39-48
11. Eringa, E. C., Bakker, W. and van Hinsbergh, V. W. (2012) Paracrine regulation of vascular tone, inflammation and insulin sensitivity by perivascular adipose tissue. Vasc. Pharmacol. 56, 204-209
12. Carling, D., Zammit, V. A. and Hardie, D. G. (1987) A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis. FEBS Lett. 223, 217-222
13. Cheung, P. C., Salt, I. P., Davies, S. P., Hardie, D. G. and Carling, D. (2000) Characterization of AMP-activated protein kinase γ subunit isoforms and their role in AMP binding. Biochem. J. 346, 659-669
14. Salt, I. P., Celler, J. W., Hawley, S. A., Prescott, A., Woods, A., Carling, D. and Hardie, D. G. (1998) AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform. Biochem. J. 334, 177-187
15. McBride, A., Ghilagaber, S., Nikolaev, A. and Hardie, D. G. (2009) The glycogen-binding domain on the AMPKβ subunit allows the kinase to act as a glycogen sensor. Cell Metab. 9, 23-34
16. Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T. et al. (2007) Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449, 496-500
17. Sakamoto, K., Göransson, O., Hardie, D. G. and Alessi, D. R. (2004) Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR. Am. J. Physiol. Endocrinol. Metab. 287, E310-E317
18. Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G. and Hardie, D. G. (2005) Calmodulin-dependent protein kinase kinase β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-19
19. 2+ /calmodulin-dependent protein kinase kinase β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21-33
20. Lin, Y. Y., Kiihl, S., Suhail, Y., Liu, S. Y., Chou, Y. H., Kuang, Z., Lu, J. Y., Khor, C. N., Lin, C. L. and Bader, J. S. (2012) Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK. Nature 482, 251-255
21. Zmijewski, J. W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E. R. and Abraham, E. (2010) Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase. J. Biol. Chem. 285, 33154-33164
22. Zhang, B. B., Zhou, G. and Li, C. (2009) AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 9, 407-416
23. Fryer, L. G., Parbu-Patel, A. and Carling, D. (2002) The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277, 25226-25232
24. Boyle, J. G., Salt, I. P. and McKay, G. A. (2010) Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabetic Med. 27, 1097-1106
25. Foretz, M., Hebrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F. and Viollet, B. (2010) Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J. Clin. Invest. 120, 2355-2369
26. Guigas, B., Bertrand, L., Taleux, N., Foretz, M., Wiernsperger, N., Vertommen, D., Andreelli, F., Viollet, B. and Hue, L. (2006) 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation. Diabetes 55, 865-874
27. Hawley, S. A., Fullerton, M. D., Ross, F. A., Schertzer, J. D., Chevtzoff, C., Walker, K. J., Peggie, M. W., Zibrova, D., Green, K. A., Mustard, K. J. et al. (2012) The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336, 918-922
28. López, J. M., Santidrián, A. F., Campàs, C. and Gil, J. (2003) 5-Aminoimidazole-4-carboxamide riboside induces apoptosis in Jurkat cells, but the AMP-activated protein kinase is not involved. Biochem. J. 370, 1027-1032
29. Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M. and Hardie, D. G. (2010) Use of cells expressing γ subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 11, 554-565
30. Sun, W., Lee, T. S., Zhu, M., Gu, C., Wang, Y., Zhu, Y. and Shyy, J. Y. (2006) Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114, 2655-2662
31. Kou, R., Sartoretto, J. and Michel, T. (2009) Regulation of Rac1 by simvastatin in endothelial cells: differential roles of AMP-activated protein kinase and calmodulin-dependent kinase kinase-β. J. Biol. Chem. 284, 14734-14743
32. Minokoshi, Y., Kim, Y. B., Peroni, O. D., Fryer, L. G., Müller, C., Carling, D. and Kahn, B. B. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343
33. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K. et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8, 1288-1295
34. Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G. and Iyengar, R. (2006) Identification and characterization of a small molecule AMPK activator that treats key components of Type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403-416
35. Scott, J. W., van Denderen, B. J., Jorgensen, S. B., Honeyman, J. E., Steinberg, G. R., Oakhill, J. S., Iseli, T. J., Koay, A., Gooley, P. R., Stapleton, D. and Kemp, B. E. (2008) Thienopyridone drugs are selective activators of AMP-activated protein kinase β1-containing complexes. Chem. Biol. 15, 1220-1230
36. Lihn, A. S., Jessen, N., Pedersen, S. B., Lund, S. and Richelsen, B. (2004) AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochem. Biophys. Res. Commun. 316, 853-858
37. Mulligan, J. D., Gonzalez, A. A., Stewart, A. M., Carey, H. V. and Saupe, K. W. (2007) Upregulation of AMPK during cold exposure occurs via distinct mechanisms in brown and white adipose tissue of the mouse. J. Physiol. 580, 677-684
38. Salt, I. P., Connell, J. M. and Gould, G. W. (2000) 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes. Diabetes 49, 1649-1656
39. Daval, M., Diot-Dupuy, F., Bazin, R., Hainault, I., Viollet, B., Vaulont, S., Hajduch, E., Ferré, P. and Foufelle, F. (2005) Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes. J. Biol. Chem. 280, 25250-25257
40. Wang, S., Zhang, M., Liang, B., Xu, J., Xie, Z., Liu, C., Viollet, B., Yan, D. and Zou, M. H. (2010) AMPKα2 deletion causes aberrant expression and activation of NAD(P)H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ. Res. 106, 1117-1128
41. Zhou, Y., Wang, D., Zhu, Q., Gao, X., Yang, S., Xu, A. and Wu, D. (2009) Inhibitory effects of A-769662, a novel activator of AMP-activated protein kinase, on 3T3-L1 adipogenesis. Biol. Pharm. Bull. 32, 993-998
42. Dzamko, N., van Denderen, B. J., Hevener, A. L., Jørgensen, S. B., Honeyman, J., Galic, S., Chen, Z. P., Watt, M. J., Campbell, D. J., Steinberg, G. R. and Kemp, B. E. (2010) AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance. J. Biol. Chem. 285, 115-122
43. Steinberg, G. R., O'Neill, H. M., Dzamko, N. L., Galic, S., Naim, T., Koopman, R., Jørgensen, S. B., Honeyman, J., Hewitt, K., Chen, Z. P. et al. (2010) Whole body deletion of AMP-activated protein kinase β2 reduces muscle AMPK activity and exercise capacity. J. Biol. Chem 285, 37198-37209
44. Yang, Z., Kahn, B. B., Shi, H. and Xue, B. Z. (2010) Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J. Biol. Chem. 285, 19051-19059
45. Reihill, J. A., Ewart, M. A. and Salt, I. P. (2011) The role of AMP-activated protein kinase in the functional effects of vascular endothelial growth factor-A and -B in human aortic endothelial cells. Vasc. Cell 3, 9
46. Galic, S., Fullerton, M. D., Schertzer, J. D., Sikkema, S., Marcinko, K., Walkley, C. R., Izon, D., Honeyman, J., Chen, Z. P., van Denderen, B. J., Kemp, B. E. and Steinberg, G. R. (2011) Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J. Clin. Invest. 121, 4903-4915
47. Sponarova, J., Mustard, K. J., Horakova, O., Flachs, P., Rossmeisl, M., Brauner, P., Bardova, K., Thomason-Hughes, M., Braunerova, R., Janovska, P. et al. (2005) Involvement of AMP-activated protein kinase in fat depot-specific metabolic changes during starvation. FEBS Lett. 579, 6105-6110
48. Watt, M. J., Holmes, A. G., Pinnamaneni, S. K., Garnham, A. P., Steinberg, G. R., Kemp, B. E. and Febbraio, M. A. (2006) Regulation of HSL serine phosphorylation in skeletal muscle and adipose tissue. Am. J. Physiol. Endocrinol. Metab. 290, E500-E508
49. Park, H., Kaushik, V. K., Constant, S., Prentki, M., Przybytkowski, E., Ruderman, N. B. and Saha, A. K. (2002) Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exercise. J. Biol. Chem. 277, 32571-32577
50. McInnes, K. J., Corbould, A., Simpson, E. R. and Jones, M. E. (2006) Regulation of adenosine 5́,monophosphate-activated protein kinase and lipogenesis by androgens contributes to visceral obesity in an estrogen-deficient state. Endocrinology 147, 5907-5913
51. Vucetic, M., Otasevic, V., Korac, A., Stancic, A., Jankovic, A., Markelic, M., Golic, I., Velickovic, K., Buzadzic, B. and Korac, B. (2011) Interscapular brown adipose tissue metabolic reprogramming during cold acclimation: interplay of HIF-1α and AMPKα. Biochim. Biophys, Acta. 1810, 1252-1261
52. Zhang, Q., Zhang, Y., Feng, H., Guo, R., Jin, L., Wan, R., Wang, L., Chen, C. and Li, S. (2011) High density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells. PLoS ONE 6, e23556
53. Wang, Z., Pini, M., Yao, T., Zhou, Z., Sun, C., Fantuzzi, G. and Song, Z. (2011) Homocysteine suppresses lipolysis in adipocytes by activating the AMPK pathway. Am J. Physiol. Endocrinol. Metab. 301, E703-E712
54. An, Z., Wang, H., Song, P., Zhang, M., Geng, X. and Zou, M. H. (2007) Nicotine-induced activation of AMP-activated protein kinase inhibits fatty acid synthase in 3T3L1 adipocytes: a role for oxidant stress. J. Biol. Chem. 282, 26793-26801
55. Lorente-Cebrián, S., Bustos, M., Marti, A., Martinez, J. A. and Moreno-Aliaga, M. J. (2009) Eicosapentaenoic acid stimulates AMP-activated protein kinase and increases visfatin secretion in cultured murine adipocytes. Clin. Sci. 117, 243-249
56. Gurriarán-Rodríguez, U., Al-Massadi, O., Roca-Rivada, A., Crujeiras, A. B., Gallego, R., Pardo, M., Seoane, L. M., Pazos, Y., Casanueva, F. F. and Camiña, J. P. (2011) Obestatin as a regulator of adipocyte metabolism and adipogenesis. J. Cell. Mol. Med. 15, 1927-1940
57. McInnes, K. J., Brown, K. A., Hunger, N. I. and Simpson, E. R. (2012) Regulation of LKB1 expression by sex hormones in adipocytes. Int. J. Obes. 36, 982-985
58. Liu, Q., Gauthier, M. S., Sun, L., Ruderman, N. and Lodish, H. (2010) Activation of AMP-activated protein kinase signaling pathway by adiponectin and insulin in mouse adipocytes: requirement of acyl-CoA synthetases FATP1 and Acsl1 and association with an elevation in AMP/ATP ratio. FASEB J. 24, 4229-4239
59. Wang, M. Y., Orci, L., Ravazzola, M. and Unger, R. H. (2005) Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc. Natl. Acad. Sci. U.S.A. 102, 18011-18016
60. Boyle, J. G., Logan, P. J., Jones, G. C., Small, M., Sattar, N., Connell, J. M., Cleland, S. J. and Salt, I. P. (2011) AMP-activated protein kinase is activated in adipose tissue of individuals with type 2 diabetes treated with metformin: a randomised glycaemia-controlled crossover study. Diabetologia 54, 1799-1809
61. Caton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J. and Sugden, M. C. (2011) Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice. Diabetes Obes. Metab. 13, 1097-1104
62. Buhl, E. S., Jessen, N., Schmitz, O., Pedersen, S. B., Pedersen, O., Holman, G. D. and Lund, S. (2001) Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 50, 12-17
63. Fisher, J. S., Gao, J., Han, D. H., Holloszy, J. O. and Nolte, L. A. (2002) Activation of AMP kinase enhances sensitivity of muscle glucose transport to insulin. Am. J. Physiol. Endocrinol. Metab. 282, E18-E23
64. Iglesias, M. A., Ye, J. M., Frangioudakis, G., Saha, A. K., Tomas, E., Ruderman, N. B., Cooney, G. J. and Kraegen, E. W. (2002) AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 51, 2886-2894
65. 2+. Am. J. Physiol. Endocrinol. Metab. 282, E1008-E1013
66. Koistinen, H. A., Galuska, D., Chibalin, A. V., Yang, J., Zierath, J. R., Holman, G. D. and Wallberg-Henriksson, H. (2003) 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes 52, 1066-1072
67. Kramer, H. F., Witczak, C. A., Fujii, N., Jessen, N., Taylor, E. B., Arnolds, D. E., Sakamoto, K., Hirshman, M. F. and Goodyear, L. J. (2006) Distinct signals regulate AS160 phosphorylation in response to insulin, AICAR, and contraction in mouse skeletal muscle. Diabetes 55, 2067-2076
68. Fazakerley, D. J., Holman, G. D., Marley, A., James, D. E., Stöckli, J. and Coster, A. C. (2009) Kinetic evidence for unique regulation of GLUT4 trafficking by insulin and AMP-activated protein kinase activators in L6 myotubes. J. Biol. Chem. 285, 1653-1660
69. Sakoda, H., Ogihara, T., Anai, M., Fujishiro, M., Ono, H., Onishi, Y., Katagiri, H., Abe, M., Fukushima, Y., Shojima, N. et al. (2002) Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes. Am. J. Physiol. Endocrinol. Metab. 282, E1239-E1244
70. Gaidhu, M. P., Fediuc, S. and Ceddia, R. B. (2006) 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes. J. Biol. Chem. 281, 25956-25964
71. Gaidhu, M. P., Perry, R. L., Noor, F. and Ceddia, R. B. (2010) Disruption of AMPKα1 signaling prevents AICAR-induced inhibition of AS160/TBC1D4 phosphorylation and glucose uptake in primary rat adipocytes. Mol. Endocrinol. 24, 1434-1440
72. Wu, X., Motoshima, H., Mahadev, K., Stalker, T. J., Scalia, R. and Goldstein, B. J. (2003) Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 52, 1355-1363
73. Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., McLauchlan, H., Klevernic, I., Arthur, J. S., Alessi, D. R. and Cohen, P. (2007) The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408, 297-315
74. Emerling, B. M., Viollet, B., Tormos, K. V. and Chandel, N. S. (2007) Compound C inhibits hypoxic activation of HIF-1 independent of AMPK. FEBS Lett. 581, 5727-5731
75. Kim, Y. M., Kim, M. Y., Kim, H. J., Roh, G. S., Ko, G. H., Seo, H. G., Lee, J. H. and Chang, K. C. (2011) Compound C independent of AMPK inhibits ICAM-1 and VCAM-1 expression in inflammatory stimulants-activated endothelial cells in vitro and in vivo. Atherosclerosis 219, 57-64
76. Henin, N., Vincent, M. F. and Van Den Berghe, G. (1996) Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim. Biophys. Acta 1290, 197-203
77. Iwatsubo, K., Bravo, C., Uechi, M., Baljinnyam, E., Nakamura, T., Umemura, M., Lai, L., Gao, S., Yan, L., Zhao, X. et al. (2012) Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase. Am. J. Physiol. Heart. Circ. Physiol. 302, H2622-H2628
78. Reshef, L., Olswang, Y., Cassuto, H., Blum, B., Croniger, C. M., Kalhan, S. C., Tilghman, S. M. and Hanson, R. W. (2003) Glyceroneogenesis and the triglyceride/fatty acid cycle. J. Biol. Chem. 278, 30413-30416
79. Gaidhu, M. P., Fediuc, S., Anthony, N. M., So, M., Mirpourian, M., Perry, R. L. and Ceddia, R. B. (2009) Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL. J. Lipid Res. 50, 704-715
80. Sakamoto, K. and Holman, G. D. (2008) Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am. J. Physiol. Endocrinol. Metab. 295, E29-E37
81. Chavez, J. A., Roach, W. G., Keller, S. R., Lane, W. S. and Lienhard, G. E. (2008) Inhibition of GLUT4 translocation by Tbc1d1, a Rab GTPase-activating protein abundant in skeletal muscle, is partially relieved by AMP-activated protein kinase activation. J. Biol. Chem. 283, 9187-9195
82. Sano, H., Kane, S., Sano, E., Mîinea, C. P., Asara, J. M., Lane, W. S., Garner, C. W. and Lienhard, G. E. (2003) Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J. Biol. Chem. 278, 14599-14602
83. Geraghty, K. M., Chen, S., Harthill, J. E., Ibrahim, A. F., Toth, R., Morrice, N. A., Vandermoere, F., Moorhead, G. B., Hardie, D. G. and MacKintosh, C. (2007) Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR. Biochem. J. 407, 231-241
84. Chen, S., Murphy, J., Toth, R., Campbell, D. G., Morrice, N. A. and Mackintosh, C. (2008) Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem. J. 409, 449-459
85. Chen, S. and Mackintosh, C. (2009) Differential regulation of NHE1 phosphorylation and glucose uptake by inhibitors of the ERK pathway and p90RSK in 3T3-L1 adipocytes. Cell. Signalling 21, 1984-1993
86. Perrotti, N., He, R. A., Phillips, S. A., Haft, C. R. and Taylor, S. I. (2001) Activation of serum- and glucocorticoid-induced protein kinase (Sgk) by cyclic AMP and insulin. J. Biol. Chem. 276, 9406-9412
87. Fischer, M., Timper, K., Radimerski, T., Dembinski, K., Frey, D. M., Zulewski, H., Keller, U., Müller, B., Christ-Crain, M. and Grisouard, J. (2010) Metformin induces glucose uptake in human preadipocyte-derived adipocytes from various fat depots. Diabetes Obes. Metab. 12, 356-359
88. Holmes, B. F., Kurth-Kraczek, E. J. and Winder, W. W. (1999) Chronic activation of 5́-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J. Appl. Physiol. 87, 1990-1995
89. Ojuka, E. O., Nolte, L. A. and Holloszy, J. O. (2000) Increased expression of GLUT-4 and hexokinase in rat epitrochlearis muscles exposed to AICAR in vitro. J. Appl. Physiol. 88, 1072-1075
90. Barnes, B. R., Long, Y. C., Steiler, T. L., Leng, Y., Galuska, D., Wojtaszewski, J. F., Andersson, L. and Zierath, J. R. (2005) Changes in exercise-induced gene expression in 5́-AMP-activated protein kinase γ 3-null and γ 3 R225Q transgenic mice. Diabetes 54, 3484-3489
91. McGee, S. L., van Denderen, B. J., Howlett, K. F., Mollica, J., Schertzer, J. D., Kemp, B. E. and Hargreaves, M. (2008) AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes 57, 860-867
92. Polakof, S., Moon, T. W., Aguirre, P., Skiba-Cassy, S. and Panserat, S. (2011) Glucose homeostasis in rainbow trout fed a high-carbohydrate diet: metformin and insulin interact in a tissue-dependent manner. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R166-R174
93. Lihn, A. S., Pedersen, S. B., Lund, S. and Richelsen, B. (2008) The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Mol. Cell. Endocrinol. 292, 36-41
94. Ducharme, N. A. and Bickel, P. E. (2008) Lipid droplets in lipogenesis and lipolysis. Endocrinology 149, 942-949
95. Egan, J. J., Greenberg, A. S., Chang, M. K., Wek, S. A., Moos, M. C. Jr. and Londos, C. (1992) Mechanism of hormonestimulated lipolysis in adipocytes: translocation of hormonesensitive lipase to the lipid storage droplet. Proc. Natl. Acad. Sci. U.S.A. 89, 8537-8541
96. Chaves, V. E., Frasson, D. and Kawashita, N. H. (2011) Several agents and pathways regulate lipolysis in adipocytes. Biochimie 93, 1631-1640
97. Pagnon, J., Matzaris, M., Stark, R., Meex, R. C., Macaulay, S. L., Brown, W., O'Brien, P. E., Tiganis, T. and Watt, M. J. (2012) Identification and functional characterization of protein kinase a phosphorylation sites in the major lipolytic protein, adipose triglyceride lipase. Endocrinology 153, 4278-4289
98. Zimmermann, R., Strauss, J. G., Haemmerle, G., Schoiswohl, G., Birner-Gruenberger, R., Riederer, M., Lass, A., Neuberger, G., Eisenhaber, F., Hermetter, A. and Zechner, R. (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306, 1383-1386
99. Ahmadian, M., Abbott, M. J., Tang, T., Hudak, C. S., Kim, Y., Bruss, M., Hellerstein, M. K., Lee, H. Y., Samuel, V. T., Shulman, G. I. et al. (2011) Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype. Cell Metab. 13, 739-748
100. Duncan, R. E., Wang, Y., Ahmadian, M., Lu, J., Sarkadi-Nagy, E. and Sul, H. S. (2010) Characterization of desnutrin functional domains: critical residues for triacylglycerol hydrolysis in cultured cells. J. Lipid Res. 51, 309-317
101. Sullivan, J. E., Brocklehurst, K. J., Marley, A. E., Carey, F., Carling, D. and Beri, R. K. (1994) Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase. FEBS Lett. 353, 33-36
102. Anthony, N. M., Gaidhu, M. P. and Ceddia, R. B. (2009) Regulation of visceral and subcutaneous adipocyte lipolysis by acute AICAR-induced AMPK activation. Obesity 17, 1312-1317
103. Yin, W., Mu, J. and Birnbaum, M. J. (2003) Role of AMP-activated protein kinase in cyclic AMP-dependent lipolysis in 3T3-L1 adipocytes. J. Biol. Chem. 278, 43074-43080
104. Koh, H. J., Hirshman, M. F., He, H., Li, Y., Manabe, Y., Balschi, J. A. and Goodyear, L. J. (2007) Adrenaline is a critical mediator of acute exercise-induced AMP-activated protein kinase activation in adipocytes. Biochem. J. 403, 473-481
105. Vaughan, M. (1962) The production and release of glycerol by adipose tissue incubated in vitro. J. Biol. Chem. 237, 3354-3358
106. Reshef, L., Hanson, R. W. and Ballard, F. J. (1970) A possible physiological role for glyceroneogenesis in rat adipose tissue. J. Biol. Chem. 245, 5979-5984
107. Brooks, B., Arch, J. R. and Newsholme, E. A. (1982) Effects of hormones on the rate of the triacylglycerol/fatty acid substrate cycle in adipocytes and epididymal fat pads. FEBS Lett. 146, 327-330
108. Gauthier, M. S., Miyoshi, H., Souza, S. C., Cacicedo, J. M., Saha, A. K., Greenberg, A. S. and Ruderman, N. B. (2008) AMP-activated protein kinase is activated as a consequence of lipolysis in the adipocyte: potential mechanism and physiological relevance. J. Biol. Chem. 283, 16514-16524
109. Bourron, O., Daval, M., Hainault, I., Hajduch, E., Servant, J. M., Gautier, J. F., Ferré, P. and Foufelle, F. (2010) Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase. Diabetologia. 53, 768-778
110. Flechtner-Mors, M., Ditschuneit, H. H., Jenkinson, C. P., Alt, A. and Adler, G. (1999) Metformin inhibits catecholamine-stimulated lipolysis in obese, hyperinsulinemic, hypertensive subjects in subcutaneous adipose tissue: an in situ microdialysis study. Diabetic Med. 16, 1000-1006
111. Zhang, T., He, J., Xu, C., Zu, L., Jiang, H., Pu, S., Guo, X. and Xu, G. (2008) Mechanisms of metformin inhibiting lipolytic response to isoproterenol in primary rat adipocytes. J. Mol. Endocrinol. 42, 57-66
112. Garton, A. J. and Yeaman, S. J. (1990) Identification and role of the basal phosphorylation site on hormone-sensitive lipase. Eur. J. Biochem. 191, 245-250
113. Su, C. L., Sztalryd, C., Contreras, J. A., Holm, C., Kimmel, A. R. and Londos, C. (2003) Mutational analysis of the hormone-sensitive lipase translocation reaction in adipocytes. J. Biol. Chem. 278, 43615-43619
114. Chakrabarti, P., English, T., Karki, S., Qiang, L., Tao, R., Kim, J., Luo, Z., Farmer, S. R. and Kandror, K. V. (2011) SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. J. Lipid Res. 52, 1693-1701
115. Takekoshi, K., Fukuhara, M., Quin, Z., Nissato, S., Isobe, K., Kawakami, Y. and Ohmori, H. (2006) Long-term exercise stimulates adenosine monophosphate-activated protein kinase activity and subunit expression in rat visceral adipose tissue and liver. Metab., Clin. Exp. 55, 1122-1128
116. Peng, I. C., Chen, Z., Sun, W., Li, Y. S., Marin, T. L., Hsu, P. H., Su, M. I., Cui, X., Pan, S., Lytle, C. Y. et al. (2012) Glucagon regulates ACC activity in adipocytes through the CAMKKβ/AMPK pathway. Am. J. Physiol. Endocrinol. Metab. 302, E1560-E1568
117. Orci, L., Cook, W. S., Ravazzola, M., Wang, M. Y., Park, B. H., Montesano, R. and Unger, R. H. (2004) Rapid transformation of white adipocytes into fat-oxidizing machines. Proc. Natl. Acad. Sci. U.S.A. 101, 2058-2063
118. Li, Y., Xu, S., Mihaylova, M. M., Zheng, B., Hou, X., Jiang, B., Park, O., Luo, Z., Lefai, E., Shyy, J. Y. et al. (2011) AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376-388
119. Giri, S., Rattan, R., Haq, E., Khan, M., Yasmin, R., Won, J. S., Key, L., Singh, A. K. and Singh, I. (2006) AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr. Metab. 3, 31
120. Samovski, D., Su, X., Xu, Y., Abumrad, N. A. and Stahl, P. D. (2012) Insulin and AMPK regulate FA translocase/CD36 plasma membrane recruitment in cardiomyocytes via Rab GAP AS160 and Rab8a Rab GTPase. J. Lipid Res. 53, 709-717
121. Schwenk, R. W., Dirkx, E., Coumans, W. A., Bonen, A., Klip, A., Glatz, J. F. and Luiken, J. J. (2010) Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes. Diabetologia 53, 2209-2219
122. Luo, B., Parker, G. J., Cooksey, R. C., Soesanto, Y., Evans, M., Jones, D. and McClain, D. A. (2007) Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes. J. Biol. Chem. 282, 7172-7180
123. Gaidhu, M. P., Frontini, A., Hung, S., Pistor, K., Cinti, S. and Ceddia, R. B. (2011) Chronic AMP-kinase activation with AICAR reduces adiposity by remodeling adipocyte metabolism and increasing leptin sensitivity. J. Lipid Res. 52, 1702-1711
124. Winder, W. W., Holmes, B. F., Rubink, D. S., Jensen, E. B., Chen, M. and Holloszy, J. O. (2000) Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J. Appl. Physiol. 88, 2219-2226
125. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H. et al. (2008) AMPK and PPARδ agonists are exercise mimetics. Cell 134, 405-415
126. MacDougald, O. A. and Lane, M. D. (1995) Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64, 345-373
127. Rosen, E. D., Walkey, C. J., Puigserver, P. and Spiegelman, B. M. (2000) Transcriptional regulation of adipogenesis. Genes Dev. 14, 1293-1307
128. Grimaldi, C., Chiarini, F., Tabellini, G., Ricci, F., Tazzari, P. L., Battistelli, M., Falcieri, E., Bortul, R., Melchionda, F., Pagliaro, P. et al. (2012) AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lympoblastic leukemia: therapeutic implications. Leukemia 26, 91-100
129. Peyton, K. J., Lui, X. M., Yu, Y., Yates, B. and Durante, W. (2012) Activation of AMP-activated protein kinase inhibits the proliferation of human endothelial cells. J. Pharmacol. Exp. Ther. 342, 827-834
130. Imamura, K., Ogura, T., Kishimoto, A., Kaminishi, M. and Esumi, H. (2001) Cell cycle regulation via p53 phosphorylation by a 5́-AMP activated protein kinase activator, 5-aminoimidazole- 4-carboxamide-1-β-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem. Biophys. Res. Commun. 287, 562-567
131. Habinowski, S. A and Witters, L. A. (2001) The effect of AICAR on adipocyte differentiation of 3T3-L1 cells. Biochem. Biophys. Res. Commun. 286, 852-856
132. Vingtdeux, V., Chandakkar, P., Zhao, H., Davies, P. and Marambaud, P. (2011) Mol. Med. 17, 1022-1030
133. Lee, H., Kang, R., Bae, S. and Yoon, Y. (2011) AICAR, an activator of AMPK, inhibits adipogenesis via the WNT/β-catenin pathway in 3T3-L1 adipocytes. Int. J. Mol. Med. 28, 65-71
134. 2+ /calmodulin-dependent protein kinase kinase, CaMKK2, inhibits preadipocyte differentiation. Endocrinology 152, 3668-3679
135. Villena, J. A., Viollet, B., Andreelli, F., Kahn, A., Vaulont, S. and Sul, H. S. (2004) Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-α2 subunit. Diabetes 53, 2242-2249
136. Zhang, W., Zhang, X., Wang, H., Guo, X., Li, H., Wang, Y., Xu, X., Tan, L., Mashek, M. T., Zhang, C. et al. (2012) AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes 61, 3114-3125
137. Lönnqvist, F., Nordfors, L., Jansson, M., Thörne, A., Schalling, M. and Arner, P. (1997) Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J. Clin. Invest. 99, 2398-2404
138. Coppari, R. and Bjørbæk, C. (2012) Leptin revisited: its mechanism of action and potential for treating diabetes. Nat. Rev. Drug Discovery 11, 692-708
139. Barré, L., Richardson, C., Hirshman, M. F., Brozinick, J., Fiering, S., Kemp, B. E., Goodyear, L. J. and Witters, L. A. (2007) Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation. Am. J. Physiol. Endocrinol. Metab. 292, E802-E811
140. Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K. et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83
141. Turer, A. T. and Scherer, P. E. (2012) Adiponectin: mechanistic insights and clinical implications. Diabetologia 55, 2319-2326
142. Gustafson, B. (2010) Adipose tissue, inflammation and atherosclerosis. J. Atheroscler. Thromb. 17, 332-341
143. Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S. and Obin, M. S. (2005) Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J. Lipid Res. 46, 2347-2355
144. Jiao, P., Chen, Q., Shah, S., Du, J., Tao, B., Tzameli, I., Yan, W. and Xu, H. (2009) Obesity-regulated upregulation of monocyte chemotactic factors in adipocytes: involvement of nuclear factor-κB and c-Jun NH2-terminal kinase pathways. Diabetes 58, 104-115
145. Kanda, H., Tateya, S., Tamori, Y., Kotani, K., Hiasa, K., Kitazawa, R., Kitazawa, S., Miyachi, H., Maeda, S., Egashira, K. and Kasuga, M. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 116, 1494-1505
146. Kitade, H., Sawamoto, K., Nagashimada, M., Inoue, H., Yamamoto, Y., Sai, Y., Takamura, T., Yamamoto, H., Miyamoto, K., Ginsberg, H. N. et al. (2012) CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes 61, 1680-1690
147. Nguyen, M. T., Favelyukis, S., Nguyen, A. K., Reichart, D., Scott, P. A., Jenn, A., Liu-Bryan, R., Glass, C. K., Neels, J. G. and Olefsky, J. M. (2007) A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282, 35279-35292
148. Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z. W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J. and Karin, M. (2005) IKK-β links inflammation to obesity-induced insulin resistanceNat. Med. 11, 191-198
149. Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T., Bandyopadyhay, G., Leung, H. Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A. K. et al. (2007) Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest. 117, 1658-1669
150. Odegaard, J. I., Ricardo-Gonzalez, R. R., Goforth, M. H., Morel, C. R., Subramanian, V., Mukundan, L., Red Eagle, A., Vats, D., Brombacher, F., Ferrante, A. W. and Chawla, A. (2007) Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116-1120
151. Solinas, G., Vilcu, C., Neels, J. G., Bandyopadhyay, G. K., Luo, J. L., Naugler, W., Grivennikov, S., Wynshaw-Boris, A., Scadeng, M., Olefsky, J. M and Karin, M. (2007) JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. Cell Metab. 6, 386-397
152. Nishimura, S., Manabe, I., Nagasaki, M., Hosoya, Y., Yamashita, H., Fujita, H., Ohsugi, M., Tobe, K., Kadowaki, T., Nagai, R. and Sugiura, S. (2007) Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes 56, 1517-1526
153. Nishimura, S., Manabe, I., Nagasaki, M., Seo, K., Yamashita, H., Hosoya, Y., Ohsugi, M., Tobe, K., Kadowaki, T., Nagai, R. and Sugiura, S. (2008) In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue. J. Clin. Invest. 118, 710-721
154. Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H. and Flier, J. S. (2006) TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025
155. Saberi, M., Woods, N. B., de Luca, C., Schenk, S., Lu, J. C., Bandyopadhyay, G., Verma, I. M. and Olefsky, J. M. (2009) Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab. 10, 419-429
156. Vandanmagsar, B., Youm, Y. H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M. and Dixit, V. D. (2011) The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179-188
157. Jeong, H. W., Hsu, K. C., Lee, J. W., Ham, M., Huh, J. Y., Shin, H. J., Kim, W. S. and Kim, J. B. (2009) Berberine suppresses pro-inflammatory responses through AMPK activation in macrophages. Am. J. Physiol. Endocrinol. Metab. 296, E955-E964
158. Sag, D., Carling, D., Stout, R. D. and Suttles, J. (2008) Adenosine 5́-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J. Immunol. 181, 8633-8641
159. Lee, H. M., Kim, J. J., Kim, H. J., Shong, M., Ku, B. J. and Jo, E. K. (2012) Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes, doi:10.2337/db12-0420
160. Vats, D., Mukundan, L., Odegaard, J. I., Zhang, L., Smith, K. L., Morel, C. R., Wagner, R. A., Greaves, D. R., Murray, P. J. and Chawla, A. (2006) Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab. 4, 13-24
161. Kohlstedt, K., Trouvain, C., Namgaladze, D. and Fleming, I. (2011) Adipocyte-derived lipids increase angiotensin-converting enzyme (ACE) expression and modulate macrophage phenotype. Basic Res. Cardiol. 106, 205-215
162. Jeon, B. T., Jeong, E. A., Shin, H. J., Lee, Y., Lee, D. H., Kim, H. J., Kang, S. S., Cho, G. J., Choi, W. S. and Roh, G. S. (2012) Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes 61, 1444-1454
163. Huypens, P., Quartier, E., Pipeleers, D. and Van de Casteele, M. (2005) Metformin reduces adiponectin protein expression and release in 3T3-L1 adipocytes involving activation of AMP activated protein kinase. Eur. J. Pharmacol. 518, 90-95
164. Rasmussen, M. S., Lihn, A. S., Pedersen, S. B., Bruun, J. M., Rasmussen, M. and Richelsen, B. (2006) Adiponectin receptors in human adipose tissue: effects of obesity, weight loss, and fat depots. Obesity 14, 28-35
165. Tang, X. X., Chen, H., Yu, S., Zhang, L., Caplan, M. J. and Chan, H. C. (2005) Lymphocytes accelerate epithelial tight junction assembly: role of AMP-activated protein kinase (AMPK). PLoS ONE 5, e12343
166. Steinberg, G. R., Michell, B. J., van Denderen, B. J., Watt, M. J., Carey, A. L., Fam, B. C., Andrikopoulos, S., Proietto, J., Görgün, C. Z., Carling, D. et al. (2006) Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 4, 465-474
167. Kelly, M., Keller, C., Avilucea, P. R., Keller, P., Luo, Z., Xiang, X., Giralt, M., Hidalgo, J., Saha, A. K., Pedersen, B. K. and Ruderman, N. B. (2004) AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem. Biophys. Res. Commun. 320, 449-454
168. Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E. et al. (2006) Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 55, 2688-2697
169. Yuen, D. Y., Dwyer, R. M., Matthews, V. B., Zhang, L., Drew, B. G., Neill, B., Kingwell, B. A., Clark, M. G., Rattigan, S. and Febbraio, M. A. (2009) Interleukin-6 attenuates insulin-mediated increases in endothelial cell signaling but augments skeletal muscle insulin action via differential effects on tumor necrosis factor-alpha expression. Diabetes 58, 1086-1095
170. Wan, Z., Ritchie, I., Beaudoin, M. S., Castellani, L., Chan, C. B. and Wright, D. C. (2012) IL-6 indirectly modulates the induction of glyceroneogenic enzymes in adipose tissue during exercise. PLoS ONE 7, e41719
171. Sakaue, H., Nishizawa, A., Ogawa, W., Teshigawara, K., Mori, T., Takashima, Y., Noda, T. and Kasuga, M. (2003) Requirement for 3-phosphoinositide-kependent dinase-1 (PDK-1) in insulin-induced glucose uptake in immortalized brown adipocytes. J. Biol. Chem. 278, 38870-38874
172. Hutchinson, D. S., Chernogubova, E., Dallner, O. S., Cannon, B. and Bengtsson, T. (2005) β-Adrenoceptors, but not alpha-adrenoceptors, stimulate AMP-activated protein kinase in brown adipocytes independently of uncoupling protein-1. Diabetologia 48, 2386-2395
173. Pulinilkunnil, T., He, H., Kong, D., Asakura, K., Peroni, O. D., Lee, A. and Kahn, B. B. (2011) Adrenergic regulation of AMP-activated protein kinase in brown adipose tissue in vivo. J. Biol. Chem. 286, 8798-8809
174. Vila-Bedmar, R., Lorenzo, M. and Fernández-Veledo, S. (2010) Adenosine 5́-monophosphate-activated protein kinase-mammalian target of rapamycin cross talk regulates brown adipocyte differentiation. Endocrinology 151, 980-992
175. Bauwens, J. D., Schmuck, E. G., Lindholm, C. R., Ertel, R. L., Mulligan, J. D., Hovis, I., Viollet, B. and Saupe, K. W. (2011) Cold tolerance, cold-induced hyperphagia, and nonshivering thermogenesis are normal in α1-AMPK-/- mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R473-R483
176. Kristensen, J. M., Johnsen, A. B., Birk, J. B., Nielsen, J. N., Jensen, B. R., Hellsten, Y., Richter, E. A. and Wojtaszewski, J. F. (2007) Absence of humoral mediated 5́AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J. Physiol. 585, 897-909
177. Martínez-Agustin, O., Herńandez-Morante, J. J., Martínez-Plata, E., Sánchez De Medina, F. and Garaulet, M. (2010) Differences in AMPK expression between subcutaneous and visceral adipose tissue in morbid obesity. Regul. Pept. 163, 31-36
178. Gauthier, M. S., O'Brien, E. L., Bigornia, S., Mott, M., Cacicedo, J. M., Xu, X. J., Gokce, N., Apovian, C. and Ruderman, N. (2011) Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem. Biophys. Res. Commun. 404, 382-387
179. Xu, X. J., Gauthier, M. S., Hess, D. T., Apovian, C. M., Cacicedo, J. M., Gokce, N., Farb, M., Valentine, R. J. and Ruderman, N. B. (2012) Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J. Lipid. Res. 53, 792-801
180. Kola, B., Christ-Crain, M., Lolli, F., Arnaldi, G., Giacchetti, G., Boscaro, M., Grossman, A. B. and Korbonits, M (2008) Changes in adenosine 5́-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. J. Clin. Endocrinol. Metab. 93, 4969-4973